Supernus Pharmaceuticals ... (SUPN)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

36.50

0.94%

After-hours Dec 13, 2024, 04:04 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07
Revenue	607.52M	667.24M	579.77M	520.40M	392.75M	408.90M	302.24M	215.00M	144.43M	122.05M	12.02M	1.48M	803.00K	106.00K	37.92M	8.89M	4.23M
Cost of Revenue	83.78M	87.22M	75.06M	52.46M	16.66M	15.36M	15.21M	11.99M	8.42M	5.76M	1.10M	-	-	-13.40M	-8.59M	336.00	-
Gross Profit	523.74M	580.02M	504.71M	467.94M	376.10M	393.54M	287.02M	203.02M	136.00M	116.29M	10.91M	1.48M	803.00K	13.51M	46.51M	8.89M	4.23M
Operating Income	-5.27M	67.30M	86.03M	173.70M	148.57M	144.44M	99.54M	54.22M	17.66M	24.23M	-61.92M	-42.17M	-37.75M	-40.12M	4.02M	-25.86M	-19.05M
Interest Income	10.45M	21.69M	10.57M	18.70M	21.62M	13.84M	2.86M	1.48M	643.00K	387.00K	400.00K	120.00K	31.00K	107.00K	122.00K	1.06M	1.77M
Pretax Income	2.77M	60.74M	73.17M	168.65M	147.49M	140.18M	100.62M	50.37M	14.97M	19.87M	-92.27M	-46.28M	-39.47M	-39.47M	4.14M	-33.48M	-17.27M
Net Income	1.32M	60.71M	53.42M	126.95M	113.06M	110.99M	57.28M	91.22M	14.02M	19.87M	-92.27M	-46.28M	56.00M	-38.46M	460.00K	-33.48M	-17.27M
Selling & General & Admin	336.36M	377.22M	304.76M	200.68M	158.43M	159.89M	137.91M	106.01M	89.20M	72.47M	55.59M	20.13M	7.93M	5.08M	4.65M	4.29M	4.01M
Research & Development	91.59M	74.55M	90.47M	75.96M	69.10M	89.21M	49.58M	42.79M	29.14M	19.59M	17.25M	23.52M	30.63M	35.15M	29.26M	30.46M	19.27M
Other Expenses	101.06M	82.63M	29.99M	15.70M	-	-	-	-15.00K	38.00K	39.00K	101.00K	-660.00K	117.00K	542.00K	-	-	-
Operating Expenses	529.01M	534.40M	425.21M	292.34M	227.52M	249.10M	187.48M	148.80M	118.34M	92.06M	72.83M	43.65M	38.55M	40.23M	33.91M	34.75M	23.28M
Interest Expense	2.42M	7.07M	23.42M	23.75M	22.71M	18.11M	1.57M	5.09M	1.23M	4.96M	7.85M	3.58M	1.87M	107.00K	122.00K	8.68M	1.77M
Selling & Marketing Expenses	99.70M	267.79M	199.71M	134.75M	40.80M	43.30M	33.80M	21.90M	19.30M	14.80M	14.60M	5.80M	-	-	94.00	499.00	-
Cost & Expenses	612.79M	621.62M	500.28M	344.80M	244.18M	264.45M	202.70M	160.79M	126.76M	97.81M	73.94M	43.65M	38.55M	40.23M	33.91M	34.75M	23.28M
Income Tax	1.45M	32.00K	19.75M	41.70M	34.43M	29.18M	43.33M	-40.85M	956.00K	4.04M	7.11M	1.14M	-16.25M	-399.00K	3.80M	1.06M	1.77M
Shares Outstanding (Basic)	54.54M	53.67M	53.10M	52.62M	52.41M	51.99M	50.76M	49.47M	47.49M	42.26M	31.82M	17.44M	13.86M	13.86M	13.86M	13.86M	13.86M
Shares Outstanding (Diluted)	55.51M	61.68M	54.36M	53.69M	53.82M	54.10M	53.30M	51.71M	51.16M	50.58M	31.85M	17.44M	13.86M	13.86M	13.86M	13.86M	13.86M
EPS (Basic)	0.02	1.13	1.01	2.41	2.16	2.13	1.13	1.84	0.29	0.47	-2.9	-2.65	3.64	-2.78	-0.21	-2.42	-1.25
EPS (Diluted)	0.02	1.04	0.98	2.36	2.10	2.05	1.08	1.76	0.28	0.32	-2.9	-2.65	3.64	-2.78	-0.21	-2.42	-1.25
EBITDA	90.04M	153.44M	129.19M	212.40M	180.42M	151.51M	107.67M	56.62M	21.77M	-4.35M	-83.68M	-41.84M	-36.73M	-38.29M	5.21M	-23.69M	-16.34M
Depreciation & Amortization	84.86M	85.63M	32.59M	20.00M	10.22M	7.06M	8.13M	2.40M	921.00K	928.00K	742.00K	871.00K	879.00K	1.19M	1.07M	1.11M	932.21K